Beta-blocker therapy stands as a cornerstone in the realm of cardiovascular medicine, offering a multifaceted approach to address various conditions. These pharmacological agents, commonly known as beta-blockers, exert their therapeutic effects by antagonizing the impact of adrenaline, resulting in a reduction of heart rate and blood pressure. Widely prescribed to manage hypertension, angina, and specific cardiac arrhythmias, beta-blockers showcase their effectiveness in diverse cardiovascular scenarios. Notably, their role extends to the management of heart failure, where they contribute to enhancing cardiac function and alleviating symptoms. Post-myocardial infarction care also heavily relies on beta-blocker therapy to prevent subsequent cardiovascular events. Beyond cardiovascular applications, these agents demonstrate versatility, occasionally finding use in mitigating symptoms associated with anxiety and migraine headaches. While generally well-tolerated, the individualized consideration of medical histories and potential contraindications is imperative in the prescription of beta-blocker therapy. A collaborative approach between healthcare providers and patients remains paramount to ensuring optimal cardiovascular health management.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine